Yes, for most people, Hashimoto's is not a reason to avoid GLP-1 medications
The retatrutide dosing after high-dose tirzepatide addresses the specific titration considerations when coming from an established GLP-1 protocol
Sept 14: Hemogenyx Pharmaceuticals could be headed to the clinic with its CAR-T therapy HEMO-CAR-T after announcing that the FDA has accepted its plan to address concerns that led the regulator to place it on a clinical hold in July 2023
After each injection, record the date, the number of units drawn, the vial concentration, the resulting milligram dose, and any side effects you notice over the following 48-72 hours
In fact, LC protects against ROS-related harm to DNA and cell membranes
Visceral fat is the deep, hidden fat that surrounds your internal organs